Chemotherapy use and survival in stage II nasopharyngeal carcinoma

Although common, the use of chemotherapy for stage II nasopharyngeal carcinoma (NPC) is controversial due to its undefined clinical benefits. We therefore conducted a retrospective cohort study to investigate whether chemotherapy confers survival gains to stage II NPC patients. A total of 251 stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Xin-Bin, Huang, Shi-Ting, Chen, Kai-Hua, Zhu, Xiao-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731982/
https://www.ncbi.nlm.nih.gov/pubmed/29254272
http://dx.doi.org/10.18632/oncotarget.21751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731982/
https://www.ncbi.nlm.nih.gov/pubmed/29254272
http://dx.doi.org/10.18632/oncotarget.21751

Ejemplares similares